Glycoprotein nonmetastatic melanoma protein B (GNMPB) as a novel biomarker for cerebral adrenoleukodystrophy
Abstract Adrenoleukodystrophy (ALD) is an X-linked peroxisomal disease caused by a mutation in the ABCD1 gene, producing mutations in the very long chain fatty acid transporter, ALD protein. Cerebral ALD (cALD) is a severe phenotype of ALD with neuroinflammation and neurodegeneration. Elevated level...
Main Authors: | Leyla A. Taghizadeh, Carina J. King, David R. Nascene, Ashish O. Gupta, Paul J. Orchard, LeeAnn Higgins, Todd W. Markowski, Erin E. Nolan, Justin W. Furcich, Troy C. Lund |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-05-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-11552-7 |
Similar Items
-
Evaluation of Neurofilament Light Chain as a Biomarker of Neurodegeneration in X-Linked Childhood Cerebral Adrenoleukodystrophy
by: Hongge Wang, et al.
Published: (2022-03-01) -
Chitotriosidase as a biomarker of cerebral adrenoleukodystrophy
by: Orchard Paul J, et al.
Published: (2011-10-01) -
Functional Characterization of Glycoprotein Nonmetastatic Melanoma Protein B in Scleroderma Fibrosis
by: Pamela J. Palisoc, et al.
Published: (2022-02-01) -
A case series of adrenoleukodystrophy in children conceived through in vitro fertilization with an egg donor
by: Crystal Chang, B.S., et al.
Published: (2023-03-01) -
Glycoprotein nonmetastatic melanoma protein B regulates lysosomal integrity and lifespan of senescent cells
by: Masayoshi Suda, et al.
Published: (2022-04-01)